
CSIR conducting 20-odd trials in race for COVID drug: DG
The Hindu
Breakthrough expected as trial with Sun Pharma inches towards completion
Council of Scientific & Industrial Research (CSIR) is presently conducting “20-odd” clinical studies with multiple industries including “five” clinical trials based on the ‘Ayush’ formulations on finding a drug to deal with COVID-19, disclosed Director-General Shekhar C. Mande on Monday. “We are taking up clinical trials tapping our traditional knowledge but from a modern science perspective for the first time in history. Another breakthrough is expected within a week or 10 days, as our clinical trial with Sun Pharma based on phyto-pharmaceuticals or plant extracts will be completed and if the results are promising, we will seek permissions for furthering research,” he said.More Related News

Popular vedic speaker and harikatha exponent Dushyant Sridhar talks about the essence of spirituality, how he cites modern examples when he talks about ancient scriptures and his journey as a storyteller so far. He also explains why he appears on advertisements, and why he walked the ramp during a recent fashion event in Chennai that celebrated classical musicians.












